Ransys Plus 20mg+12.5mg

Tablet
Olmesartan Medoxomil + Hydrochlorothiazide
Healthcare Pharmaceuticals

Other Strength:
- Ransys 10mg
- Ransys 20mg
- Ransys 40mg

Alternative:
- Olmesan Plus 20mg+12.5mg
- Orbas Plus 20mg+12.5mg
- Xyotil Plus 20mg+12.5mg
- Tenizide 20mg+12.5mg
- Olmecar Plus 20mg+12.5mg



Ransys Plus
Description
Ransys Plus® is a combination preparation of Olmesartan Medoxomil & Hydrochlorothiazide. Olmesartan blocks the vasoconstrictor effects of Angiotensin II by selectively blocking the binding of Angiotensin II to the AT1 receptor in vascular smooth muscle. Its action is, therefore, independent of the pathways for Angiotensin II synthesis.
Hydrochlorothiazide is a Thiazide Diuretic that affects the renal tubular mechanisms of electrolyte reabsorption, directly increasing excretion of sodium and chloride in approximately equivalent amounts. Indirectly, the diuretic action of Hydrochlorothiazide reduces plasma volume, with consequent increases in plasma renin activity, increases in aldosterone secretion, increases in urinary potassium loss, and decreases in serum potassium. Co-administration of an Angiotensin II receptor antagonist (like Olmesartan Medoxomil) tends to reverse the potassium loss associated with these diuretics (like Hydrochlorothiazide).

Indications
Ransys Plus® is indicated for the treatment of hypertension. This combination preparation is indicated in patients whose blood pressure is not adequately controlled on Olmesartan alone. It is not indicated for initial therapy. Ransys Plus may also be used as initial therapy in patients who are likely to need multiple antihypertensive agents to achieve their blood pressure goals.
Supply:
Ransys Plus® 20/12.5 tablet: Each box contains 5x6’s tablets in Alu-Alu blister pack.

এই পাতাটি ২৮২ বার দেখা হয়েছে